Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-31 · accession 0001437749-25-002623 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-03 | 2025-01-31 | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | M - OptEx | — | +233.3K | 283.3K | +467% | — |
| D | 2025-02-03 | 2025-01-31 | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | M - OptEx | $0.00 | -233.3K | 466.7K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | M | A | 233,333 | — | 283,333 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Restricted Stock Unit | 2025-01-31 | M | D | 233,333 | $0.00 | 466,667 | D | — · — to — | 233,333 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F2) The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date. |